Comments
Shilpa Medicare Ltd, which had invested in Nu Therapeutics (P) Ltd last year, has now acquired a controlling stake in it.
Nu Therapeutics was established to manufacture oral fast dissolving thin strip dosage jointly with others and expects to start production shortly. Shilpa Medicare hopes the acquisition would help it penetrate niche formulation markets.
Shilpa shares were up Rs 16.20 (6.04 per cent) on the BSE at 12.55 pm today with about 34,300 shares having been traded.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.